Precipio, Inc. — Director's Dealing 2014

Nov 6, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TRANSGENOMIC INC (TBIO)
CIK: 0001043961
Period of Report: 2014-10-31

Reporting Person: Richards Leon (Chief Accounting Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$7.56	2023-01-01	Common Stock (4166)		Direct
Stock Option (Right to Buy)	$4.20	2023-05-03	Common Stock (1458)		Direct
Stock Option (Right to Buy)	$5.54	2024-02-18	Common Stock (3000)		Direct

Footnotes

F1: The option was granted on 1/1/2013 and is exercisable in three equal annual installments. The first installment became exercisable on January 1, 2014, and the next two installments will become exercisable on the second and third anniversary of the date of grant, subject to the reporting person's continued employment with the issuer on each such date.

F2: The option was granted on 5/3/2013 and is exercisable in three equal annual installments. The first installment became exercisable on May 3, 2014, and the next two installments will become exercisable on the second and third anniversary of the date of grant, subject to the reporting person's continued employment with the issuer on each such date.

F3: The option was granted on 2/18/2014 and is exercisable as it vests. The option vests over a three-year period in substantially equal installments, with 1/3 of the shares subject to the option vesting on each of the first, second and third anniversary of the date of grant, subject to the reporting person's continued employment with the issuer on each such date.